Barbara Adamczyk

Sometimes: analysis of biomolecules (proteins/PTMs, oligonucleotides), UHPLC, LC-MS/MS otherwise: travel, parenting, photography, rowing & running enthusiast

[Annette Bak @annette_bak]

Great opportunity to join #AdvancedDrugDelivery at @AstraZeneca #RDBoston #waltham in Liping Zhou’s team, a great, science driven and fun loving team. You will have a good time! Please consider applying! #ChemJobber, #RTs appreciated https://t.co/nhqmz3odZN

[Annette Bak @annette_bak]

Have experience in #nanoparticle mediated delivery of #mRNA to facilitate #vaccines & #genetherapy? Then this #AdvancedDrugDelivery position in @AstraZeneca #sweden may just be it for you. You will have a good time and looking forward to meeting you. https://t.co/IqwxkNpeZ7

[Annette Bak @annette_bak]

4 great opportunities aimed at delivering RNA/new mods therapies. The positions are in our #AdvancedDrugDelivery team ⁦@AstraZeneca⁩ in #Waltham MA. Would appreciate shares/ RTs. Especially need help locating great #LipidChemists and #PolymerChemists https://t.co/F7bCcdt2Lo

[C&EN (Chemical & Engineering News) @cenmag]

.@CarolynBertozzi's role in pushing glycoscience forward is undeniable, but peers are quick to stress the broader impact of the scientists she’s trained. As her life gets busier, she remains dedicated to raising new generations of glyco evangelists. https://t.co/mr9ATIyrCI

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Interested in #celltherapies? Here's a new collection of freely accessible reviews https://t.co/3KOylu76j2 - covering regulatory T cells for immune disorders, gamma delta T cells for cancer and engineered haematopoietic stem cells for blood disorders

[Annette Bak @annette_bak]

Check out this job: Associate Director - Preformulation and Biopharmaceutics in Advanced Drug Delivery in Sweden. Ready to come and work with us on cool #drugdelivery ? Interesting #biopharmaceutics problems? Questions pls let me know. RTs appreciated https://t.co/lWwrPmpfMq

[GutMicrobiota Health @GMFHx]

Human milk can be considered literally a "magic fluid". This review explores the role of glycans, abundant in milk, in shaping the development of the infant and the infant-gut microbiota via @AnnualReviews https://t.co/84wBXikZSX

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Targeted protein degradation: expanding the toolbox https://t.co/Qj8VI4mnRW - a new article discussing opportunities for exploiting more of the ~600 E3 ligases when developing PROTACs

[Roisin OFlaherty @irishglycogirl]

Our newest publication showcases the importance of IgG Fc glycosylation in children with unexplained recurrant respiratory infections, published in Journal of Allergy and Clinical Immunology:
https://t.co/TvgZz7jA0A

[Robert K. Bradley @bradleybio]

Interesting collection in @nature about the promise of RNA-based therapy https://t.co/2Y0k2ZlVPu. We're excited about these approaches for correcting mis-splicing in cancer https://t.co/nOzFB7krXc

[ACS Publications Bio & Med Chem Content @ACSBioMed]

Alectos and Merck reveal the discovery of MK-8719, the first clinical O-GlcNAcase (OGA) inhibitor as a potential treatment for tauopathies https://t.co/yI8pVtsNLD

[Pippa Cosper MD, PhD @pipcosper]

This is the rejection letter for the work that just won the Nobel Prize. Don’t stop believing!
I should save all of mine and maybe one day some stranger will think it’s an amazing relic and tweet it...

[Barbara Adamczyk @adamczyk_b]

Great to see the NIST Interlaboratory study on mAb glycomics published in MCP. This article has broken the record for the highest number of co-authors I have even taken part in to date ;) An interesting read but also unsettling to see the diversity of results.

[Pastel BioScience @PastelBio]

NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods | https://t.co/MP1XAgnpLZ #proteomics

[Sayantani Chatterjee @csayantani9]

Yay yay yay! My first...first-author paper is out! A big thank you to @mtandersen_lab and all the contributors 😊
@PastelBio @MQMolSci https://t.co/cKlc2m5n3k

[Matt Pratt @MattRPratt]

Adding an O-GlcNAc or "O-GlcNAc Engineering" can improve the serum stability and in vivo efficacy of therapeutic peptides. Our latest paper out in JACS with @sevakat1, Tom Gardella, Denise Wootten, Patrick Sexton, and Patsy McDonald. https://t.co/qvzdeySrjc

[CarboMet @CarboMet_EU]

A perspective was written by leading scientists in the field of glycoscience and analytical chemistry on the challenges and solutions of carbohydrate sequencing. You can access this from the CarboMet website https://t.co/VGzMAIA5tY
or from JACS https://t.co/UNrpIvIS4R

[Nature Reviews Drug Discovery @NatRevDrugDisc]

For readers interested in the technology of antibody-drug conjugates such as Roche's just-approved polatuzumab vedotin, here's a comprehensive review https://t.co/AIH6zhnvBa

[Tomislav Čaval @TomislavCaval]

Great #Glycotime resource.

Validated library of 43 mAbs targeting glycosyltransferases involved in O-glycosylation
https://t.co/BhMSgKWubV

[Biotweeps @biotweeps]

I’m proud to announce that @BioRender (a project my team & I have poured our hearts into for 2 yrs) has 200K+ figures by 95K+ scientists 👨🏽‍🔬👩‍🔬! We built this so you could stop struggling to make figures in PPT 🔬 Also, the base version is free, forever 💜 https://t.co/KJpyxgxeQt